March 28, 2011 – The Alzheimer’s Drug Discovery Foundation (ADDF) announced that it has awarded a grant of $249,810 to Yuma Therapeutics Corporation (Yuma) to develop small molecules to treat Alzheimer’s disease.The award will fund work to develop Yuma’s innovative disease-modifying pharmaceutical compounds that target neurofibrillary tangles resulting from abnormal forms of the protein tau, which represents a promising new approach with potential to affect disease progression in Alzheimer’s disease... [PDF] Alzheimer’s Drug Discovery Foundation's Press Release -
